<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03218540</url>
  </required_header>
  <id_info>
    <org_study_id>HE591258</org_study_id>
    <nct_id>NCT03218540</nct_id>
  </id_info>
  <brief_title>Stroke Volume Variation vs Central Venous Pressure Guidance Fluid Management in Endovascular Aortic Repair</brief_title>
  <official_title>Directed Fluid Therapy Based on Stroke Volume Variations Improves Fluid Management in Endovascular Aortic Repair for Aortic Aneurysm Patients: a Randomized Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Khon Kaen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Khon Kaen University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hypothesis: Fluid management guided by stroke volume variation (SVV), compared with central
      venous pressure (CVP), guidance results in better clinical outcomes.

      Primary outcomes: Perioperative, up to 48 h postoperative, serum lactate and creatinine
      level.

      Methods: Adult patients undergoing endovascular aortic aneurysm repair (EVAR) will be
      randomized into 2 groups: SVV group managed by SVV guidance and CVP group managed by CVP
      guidance.

      Outcome analyses: Compare serum lactate, creatinine as well as other postoperative
      complications between both groups.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Objective: To compare postoperative clinical outcome in adult patient undergoing EVAR.

      Primary outcome: Postoperative serum lactate and creatinine.

      Secondary outcome: Postoperative complications.

      Methods: Eligible patients will be randomized to 2 groups. Both groups will be managed
      intraoperatively in the same way, except fluid management protocol. SVV group will be managed
      according to stroke volume variation (SVV) protocol, i.e., control SVV 10-13% and give fluid
      when SVV &gt; 13%. CVP group will be managed using central venous pressure (CVP) protocol, i.e.,
      control CVP 8-12 mmHg and give fluid when CVP &lt; 8 mmHg.

      Outcome analyses: Postoperative serum lactate and creatinine of both groups will be compared
      using unpaired Student-t test. Secondary outcomes will be compared using chi-square test.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 1, 2017</start_date>
  <completion_date type="Actual">July 31, 2017</completion_date>
  <primary_completion_date type="Actual">July 31, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Group SVV: fluid management guided by stroke volume variation (SVV) protocol Group CVP: fluid management guided by central venous pressure (CVP) protocol</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
    <masking_description>The patient is anesthetized, thus unaware type of treatment. The assessor is blinded of the monitor</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>lactate and creatinine level</measure>
    <time_frame>at the end of surgery up to 48 hours</time_frame>
    <description>serum lactate and creatinine level</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Postoperative Complications</condition>
  <arm_group>
    <arm_group_label>SVV group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Fluid management protocol</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CVP group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Fluid management protocol</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Fluid management protocol</intervention_name>
    <description>SVV protocol: keep SVV 10-13% and give fluid when SVV &gt; 13% CVP protocol: keep CVP 8-12 mmHG and give fluid when CVP &lt; 8 mmHg</description>
    <arm_group_label>SVV group</arm_group_label>
    <arm_group_label>CVP group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. 40-80 years old

          2. Patient had aortic aneurysm both thoracic and abdominal types

          3. Scheduled for elective EVAR procedures

          4. New York Heart Association (NYHA) or American society of Anesthesiology (ASA)
             classification I-III

          5. Body mass index (BMI) 18-24 kg/m2

          6. Provided informed consent before surgery

        Exclusion Criteria:

          1. Scheduled for emergency or redo surgery

          2. Received prior fluid therapy (&gt;2,500 ml/day over the 48 h before the surgery)

          3. Presence of congenital heart disease, cardiomyopathy, rheumatic heart disease, or
             significant arrhythmia or cardiopulmonary dysfunction, or significant renal or liver
             diseases

          4. Preoperative use of vasoactive drugs (e.g. digoxin, nitroglycerine, nifedipine) for â‰¥3
             months

          5. Difficulty (or contraindication to) placing a central venous catheter

          6. Inability to cooperate (e.g. mental disorder, disturbance of consciousness, mental
             retardation)

          7. Presence of blood-borne infectious disease (e.g. syphilis, acquired immunodeficiency
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thepakorn Sathitkarnmanee</last_name>
    <role>Study Chair</role>
    <affiliation>Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Faculty of Medicine, Khon Kaen University</name>
      <address>
        <city>Khon Kaen</city>
        <zip>40002</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <reference>
    <citation>Ramsingh DS, Sanghvi C, Gamboa J, Cannesson M, Applegate RL 2nd. Outcome impact of goal directed fluid therapy during high risk abdominal surgery in low to moderate risk patients: a randomized controlled trial. J Clin Monit Comput. 2013 Jun;27(3):249-57. doi: 10.1007/s10877-012-9422-5. Epub 2012 Dec 22.</citation>
    <PMID>23264068</PMID>
  </reference>
  <results_reference>
    <citation>Kothandan H, Haw Chieh GL, Khan SA, Karthekeyan RB, Sharad SS. Anesthetic considerations for endovascular abdominal aortic aneurysm repair. Ann Card Anaesth. 2016 Jan-Mar;19(1):132-41. doi: 10.4103/0971-9784.173029. Review.</citation>
    <PMID>26750684</PMID>
  </results_reference>
  <results_reference>
    <citation>Brandstrup B. Fluid therapy for the surgical patient. Best Pract Res Clin Anaesthesiol. 2006 Jun;20(2):265-83. Review.</citation>
    <PMID>16850777</PMID>
  </results_reference>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 10, 2017</study_first_submitted>
  <study_first_submitted_qc>July 13, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 14, 2017</study_first_posted>
  <last_update_submitted>August 15, 2017</last_update_submitted>
  <last_update_submitted_qc>August 15, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 18, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Khon Kaen University</investigator_affiliation>
    <investigator_full_name>Thepakorn Sathitkarnmanee</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>stroke volume variation</keyword>
  <keyword>central venous pressure</keyword>
  <keyword>serum lactate</keyword>
  <keyword>serum creatinine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Postoperative Complications</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

